PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse/human CD44, 100 μg
PE/Dazzle™ 594 anti-mouse/human CD44, 25 μg
PE/Dazzle™ 594 anti-mouse/human CD45R/B220, 100 μg
PE/Dazzle™ 594 anti-mouse/human CD45R/B220, 25 μg
PE/Dazzle™ 594 anti-mouse/human Helios, 100 tests
PE/Dazzle™ 594 anti-mouse/human Helios, 25 tests
PE/Dazzle™ 594 anti-mouse/human KLRG1 (MAFA), 100 μg
PE/Dazzle™ 594 anti-mouse/human KLRG1 (MAFA), 25 μg
PE/Dazzle™ 594 anti-mouse/rat/human CD27, 100 μg
PE/Dazzle™ 594 anti-mouse/rat/human CD27, 25 μg
PerCP anti-mouse CD117 (c-Kit), 100 μg
PerCP anti-mouse CD117 (c-Kit), 25 μg
PerCP anti-mouse CD11c, 100 μg
PerCP anti-mouse CD11c, 25 μg
PerCP anti-mouse CD19, 100 μg
PerCP anti-mouse CD19, 25 μg